Cargando…

Mitochondrial Dysfunction: An Emerging Link in the Pathophysiology of Cardiorenal Syndrome

The crosstalk between the heart and kidney is carried out through various bidirectional pathways. Cardiorenal syndrome (CRS) is a pathological condition in which acute or chronic dysfunction in the heart or kidneys induces acute or chronic dysfunction of the other organ. Complex hemodynamic factors...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Shuqing, Zhang, Bingxuan, Li, Yumeng, Xu, Xia, Lv, Jiayu, Jia, Qiulei, Chai, Ruoning, Xue, Wenjing, Li, Yuan, Wang, Yajiao, Wu, Huaqin, Song, Qingqiao, Hu, Yuanhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914047/ https://www.ncbi.nlm.nih.gov/pubmed/35282359 http://dx.doi.org/10.3389/fcvm.2022.837270

Ejemplares similares

SGLT2 inhibitors in the treatment of type 2 cardiorenal syndrome: Focus on renal tubules
por: Wang, Yajiao, et al.
Publicado: (2023)

The Application of Angiotensin Receptor Neprilysin Inhibitor in Cardiovascular Diseases: A Bibliometric Review From 2000 to 2022
por: Xu, Xia, et al.
Publicado: (2022)

Cardiac Remodeling in Heart Failure: Role of Pyroptosis and Its Therapeutic Implications
por: Chai, Ruoning, et al.
Publicado: (2022)

Blood urea nitrogen to creatinine ratio and long-term survival in patients with chronic heart failure
por: Wang, Yajiao, et al.
Publicado: (2023)

Efficacy and safety of Linggui Zhugan decoction in the treatment of chronic heart failure with Yang deficiency: A protocol for systematic review and meta-analysis
por: Li, Yumeng, et al.
Publicado: (2021)

Tanshinone IIA inhibits cardiomyocyte pyroptosis through TLR4/NF-κB p65 pathway after acute myocardial infarction
por: Chai, Ruoning, et al.
Publicado: (2023)

Trends in mitochondrial unfolded protein response research from 2004 to 2022: A bibliometric analysis
por: Ye, Zelin, et al.
Publicado: (2023)

Effects of garlic supplementation on components of metabolic syndrome: a systematic review, meta-analysis, and meta-regression of randomized controlled trials
por: Fu, Zhenyue, et al.
Publicado: (2023)

Research trends and hotspots evolution of cardiac amyloidosis: a bibliometric analysis from 2000 to 2022
por: Fu, Zhenyue, et al.
Publicado: (2023)

Circadian rhythm in cardiovascular diseases: a bibliometric analysis of the past, present, and future
por: Chai, Ruoning, et al.
Publicado: (2023)

Psycho-Cardiological Disease: A Bibliometric Review From 2001 to 2021
por: You, Yaping, et al.
Publicado: (2022)

Cardiac Rehabilitation: A Bibliometric Review From 2001 to 2020
por: Yuan, Guozhen, et al.
Publicado: (2021)

Cardiorenal Syndromes: Pathophysiology to Prevention
por: McCullough, Peter A.
Publicado: (2010)

Editorial: New Advances in Cardiorenal Syndrome
por: Calvier, Laurent, et al.
Publicado: (2022)

Cardiorenal syndrome and diabetes: an evil pairing
por: Méndez Fernández, Ana Belén, et al.
Publicado: (2023)

An Update on the Pathophysiology and Treatment of Cardiorenal Syndrome
por: Raina, Rupesh, et al.
Publicado: (2020)

Biomarkers in Cardiorenal Syndrome and Potential Insights Into Novel Therapeutics
por: Chung, Edmund Y. M., et al.
Publicado: (2022)

Immunomodulatory Approaches in Diabetes-Induced Cardiorenal Syndromes
por: Ammar, Lama A., et al.
Publicado: (2021)

Toward Human Models of Cardiorenal Syndrome in vitro
por: Gabbin, Beatrice, et al.
Publicado: (2022)

Chronic Secondary Cardiorenal Syndrome: The Sixth Innovative Subtype
por: Zhang, Yipeng, et al.
Publicado: (2021)

The effects of ACEI/ARB, aldosterone receptor antagonists and statins on preventing recurrence of atrial fibrillation: A protocol for systematic review and network meta-analysis
por: Jia, Qiulei, et al.
Publicado: (2021)

Comparative efficacy and safety of wenxin granule combined with antiarrhythmic drugs for atrial fibrillation: A protocol for a systematic review and network meta-analysis
por: Shi, Shuqing, et al.
Publicado: (2021)

Cardiorenal Syndrome in COVID-19 Patients: A Systematic Review
por: Lin, Ling, et al.
Publicado: (2022)

Mitochondrial Dysfunction in Cardiorenal Syndrome 3: Renocardiac Effect of Vitamin C
por: Neres-Santos, Raquel Silva, et al.
Publicado: (2021)

New insights into the pathophysiological mechanisms underlying cardiorenal syndrome
por: Wang, Jin, et al.
Publicado: (2020)

Emerging Treatments of Cardiorenal Syndrome: An Update on Pathophysiology and Management
por: Verma, Deepak, et al.
Publicado: (2021)

Update on the Classification and Pathophysiological Mechanisms of Pediatric Cardiorenal Syndromes
por: Ceravolo, Giorgia, et al.
Publicado: (2021)

Meta-Analysis on the Safety and Cardiorenal Efficacy of SGLT2 Inhibitors in Patients Without T2DM
por: Li, Lu-Feng, et al.
Publicado: (2021)

Mechanisms of Cardiorenal Protection With SGLT2 Inhibitors in Patients With T2DM Based on Network Pharmacology
por: Wang, Anzhu, et al.
Publicado: (2022)

Tricuspid regurgitation, right ventricular function, and renal congestion: a cardiorenal triangle
por: Forado-Benatar, Ilana, et al.
Publicado: (2023)

Pathophysiology of Cardiorenal Syndrome and Use of Diuretics and Ultrafiltration as Volume Control
por: Lim, Sung Yoon, et al.
Publicado: (2021)

Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering
por: Charytan, David M, et al.
Publicado: (2023)

Angiotensin-converting enzyme 2 and COVID-19 in cardiorenal diseases
por: Sharma, Ravindra K., et al.
Publicado: (2021)

Mitochondrial Impairment: A Link for Inflammatory Responses Activation in the Cardiorenal Syndrome Type 4
por: Amador-Martínez, Isabel, et al.
Publicado: (2023)

Mitochondrial dysfunction in heart failure and its therapeutic implications
por: Liu, Miaosen, et al.
Publicado: (2022)

Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome
por: Willemsen, Suzan, et al.
Publicado: (2011)

Beyond the Cardiorenal Syndrome: Pathophysiological Approaches and Biomarkers for Renal and Cardiac Crosstalk
por: Buliga-Finis, Oana Nicoleta, et al.
Publicado: (2022)

Insights of Worsening Renal Function in Type 1 Cardiorenal Syndrome: From the Pathogenesis, Biomarkers to Treatment
por: Fu, Kang, et al.
Publicado: (2021)

Estimated plasma volume status: association with congestion, cardiorenal syndrome and prognosis in precapillary pulmonary hypertension
por: Yogeswaran, Athiththan, et al.
Publicado: (2023)

Cardiovascular and Renal Links along the Cardiorenal Continuum
por: García-Donaire, José A., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_iq6locbqauvn2mt65ej8d62ub5